Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

CDC issues warning of drug-resistant stomach infection spreading across US

An increasingly common strain of the debilitating stomach illness Shigella cannot be treated with antibiotics, the CDC warns

Bevan Hurley
Monday 27 February 2023 11:07 EST
Comments
CDC issues warning over the rise of drug-resistant bacteria

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

A new warning has been issued by the Centers for Disease Control and Prevention about a drug-resistant strain of the crippling stomach bug Shigella that is spreading rapidly across the United States.

Of the approximately 450,000 Shigellis infections in the US last year, the CDC found around 5 per cent of those were “extensively drug resistant”, or XDR, up from zero in 2015.

While Shigellos had predominantly been found in children under four, the CDC said it was noticing an increase in adults, in particular gay and bisexual men, the homeless, travellers from overseas and people living with HIV.

The gastrointestinal bug causes inflammatory diarrhea and the increasingly common drug-resistant strain can’t be treated with common antibiotics, the CDC said in an advisory on Friday.

Shigella is easily transmissible through person-to-person contact, or consuming contaminated food and water.

“XDR Shigella bacteria have limited antimicrobial treatment options, are easily transmissible, and can spread antimicrobial resistance genes to other enteric bacteria,” the CDC said.

The percentage of Shigella cases caused by extensively drug-resistant has increased from zero in 2015 to five per cent in 2022
The percentage of Shigella cases caused by extensively drug-resistant has increased from zero in 2015 to five per cent in 2022 (CDC)

The CDC said it was monitoring cases closely and is holding a briefing for health professionals on Tuesday.

Health officials said in Friday’s alert that there are no CDC recommendations for treating the drug resistant shigellosis infections in the United States.

“Healthcare providers treating XDR shigellosis should consult with a specialist knowledgeable in treating antibiotic-resistant bacteria to determine the best treatment options,” the CDC stated.

The most commonly prescribed treatments for non-resistant forms of Shigella are azithromycin, ciprofloxacin, or ceftriaxone. Apart from bloody and prolonged diarrhea, symptoms include fever and stomach cramps.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in